Atlas Trials

A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's Disease

Clinical trial NCT05476783 · TERMINATED

Trial details

NCT number
NCT05476783
Sponsor
TrueBinding, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2022-09-15
Primary completion
2023-11-17
Enrollment
119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.